128 related articles for article (PubMed ID: 37468393)
21. Renal cell carcinoma with tumor thrombus growing against the direction of venous return: an indicator of complicated surgery and poor prognosis.
Liu Z; Li Y; Zhao X; Ge L; Zhu G; Hong P; Tang S; Zhang S; Tian X; Wang S; Liu C; Zhang H; Ma L
BMC Surg; 2021 Dec; 21(1):443. PubMed ID: 34963464
[TBL] [Abstract][Full Text] [Related]
22. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
[TBL] [Abstract][Full Text] [Related]
23. A proposal of post-operative nomogram for overall survival in patients with renal cell carcinoma and venous tumor thrombus.
Gu L; Wang Z; Chen L; Ma X; Li H; Nie W; Peng C; Li X; Gao Y; Zhang X
J Surg Oncol; 2017 Jun; 115(7):905-912. PubMed ID: 28230236
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of renal cell carcinoma with associated venous tumor thrombus: experience from a large cohort and short time span in a single center.
Chen Z; Yang F; Ge L; Qiu M; Liu Z; Liu C; Tian X; Zhang S; Ma L
BMC Cancer; 2021 Jul; 21(1):766. PubMed ID: 34215223
[TBL] [Abstract][Full Text] [Related]
25. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus.
Gu Y; Fu Y; Pan X; Zhou Y; Ji C; Zhao T; Miao H; Lv H; Da J; Ge J; Wang L; Qu L; Ge S; Guo H; Zhou W
Front Oncol; 2023; 13():1117595. PubMed ID: 36776325
[TBL] [Abstract][Full Text] [Related]
27. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
28. Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy.
Verbiest A; Couchy G; Job S; Caruana L; Lerut E; Oyen R; de Reyniès A; Tosco L; Joniau S; Van Poppel H; Van Raemdonck D; Van Den Eynde K; Wozniak A; Zucman-Rossi J; Beuselinck B
Eur Urol; 2018 Oct; 74(4):474-480. PubMed ID: 29463434
[TBL] [Abstract][Full Text] [Related]
29. Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
Correa AF; Jegede OA; Haas NB; Flaherty KT; Pins MR; Adeniran A; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Dutcher JP; DiPaola RS; Carducci MA; Uzzo RG
Eur Urol; 2021 Jul; 80(1):20-31. PubMed ID: 33707112
[TBL] [Abstract][Full Text] [Related]
30. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
[TBL] [Abstract][Full Text] [Related]
31. Prognostic indicators for survival in renal cell carcinoma with venous thrombus and development of predictive nomograms.
Tian J; Zeng X; Guan W; Hu Z; Yang C
Transl Androl Urol; 2022 Oct; 11(10):1374-1388. PubMed ID: 36386258
[TBL] [Abstract][Full Text] [Related]
32. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC).
Weiss VL; Braun M; Perner S; Harz A; Vorreuther R; Kristiansen G; Müller SC; Ellinger J
BJU Int; 2014 Feb; 113(2):209-17. PubMed ID: 24053185
[TBL] [Abstract][Full Text] [Related]
34. Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.
Shah PH; Lyon TD; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA; Thompson RH
BJU Int; 2019 Feb; 123(2):270-276. PubMed ID: 30113768
[TBL] [Abstract][Full Text] [Related]
35. Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus.
Shi X; Pang Q; Nian X; Jiang A; Shi H; Liu W; Gan X; Gao Y; Yang Y; Ji J; Tan X; Xiao C; Zhang W
Sci Rep; 2023 Jun; 13(1):9778. PubMed ID: 37328520
[TBL] [Abstract][Full Text] [Related]
36. The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience.
Liu Z; Tang S; Tian X; Zhang H; Wang G; Zhang S; Ma L
BMC Cancer; 2020 Jan; 20(1):61. PubMed ID: 31992244
[TBL] [Abstract][Full Text] [Related]
37. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
[TBL] [Abstract][Full Text] [Related]
39. Imaging predictors for assessment of inferior vena cava wall invasion in patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective study.
Wang BS; Li YZ; Fang YY; Zhang SD; Ma LL
Chin Med J (Engl); 2020 Sep; 133(17):2078-2083. PubMed ID: 32898352
[TBL] [Abstract][Full Text] [Related]
40. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
Parker AS; Eckel-Passow JE; Serie D; Hilton T; Parasramka M; Joseph RW; Wu KJ; Cheville JC; Leibovich BC
Eur Urol; 2014 Nov; 66(5):929-35. PubMed ID: 24388441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
